Acorda Therapeutics Inc (ACORQ)

[INFINITI]

On May 10, 2023, Acorda Therapeutics, Inc. (the “Company”) issued a press release announcing that the Company will make a cash interest payment of approximately $6.2 million in satisfaction of the interest payment due on June 1, 2023, as provided for under the indenture governing the Company’s 6.00% Convertible Senior Secured Notes due 2024 (the “Notes”). The Company will make the interest payment using cash that was placed in escrow when the Notes were issued, which is reported on the Company’s balance sheet as restricted cash. The June 1 payment is the last payment in which the Company has the option to pay in cash or shares of its common stock. All future payments will be made in cash. A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.